Clinical Ethical Issues Regarding Hereditary Breast Cancer and Ovarian Cancer Syndrome and the Preimplantation Genetic Test for a Monogenic/Single-Gene Defect in Japan
摘要
Oncofertility is an interdisciplinary medical field that bridges biomedicine and social sciences and examines issues related to individual patients’ fertility options, decisions, and goals with respect to a cancer diagnosis, treatment, and survivorship. Clinically, oncofertility aims to achieve physical, mental, and social well-being for cancer patients of reproductive or pre-reproductive age by providing assistance based on biomedicine and social sciences to enable patients and their families to have children and/or to reexamine what it means to have children. In Japan, the Japan Society for Fertility Preservation was established in 2012, and in 2014, the Japan Society of Obstetrics and Gynecology (JSOG) officially stated its views on medically indicated cryopreservation. Three years later, in 2017, the Japan Society of Clinical Oncology (JSCO) published the “JSCO Clinical Practice Guidelines 2017 for Fertility Preservation in Childhood, Adolescent and Young Adult Cancer Patients” [1, 2].